Our Pipeline
Notal Vision is committed to transforming the detection and diagnosis of ocular diseases. As new therapies come to market and the population ages, the costs of delivering healthcare continue to rise. Extending ophthalmic and systemic disease
management beyond the classical clinic setting can positively impact the economics of healthcare as well as the medical benefits that patients experience.
Product Candidate |
Research |
Clinical |
Registration |
Launched |
|
|
|
|
|
|
|
|
|
|
ForeseeHome® |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NOA OCT Analyzer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home-OCT |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Launched |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Registration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research |
|
|
|
|
|
|
|
|
|
ForeseeHome® |
|
NOA OCT Analyzer |
|
Home-OCT |
Product candidate
At Notal Vision, we seek to understand the unmet medical needs associated with ophthalmic diseases and their treatments. We want to design home monitoring solutions that are easy to use and improve doctors’ ability to provide optimal vision
outcomes for their patients. Partnering with eye specialists to validate our understanding of the unmet need and the complexities associated with delivering eye care today, we continually challenge ourselves to provide value-enhancing
approaches for patients and their families, physicians, and payers.
Candidate |
Overview |
Disease State |
Stage of Development |
ForeseeHome®
|
Demonstrate functional benefit in patients with good VA following ERM treatment
|
Epiretinal membrane
|
Clinical
|
ForeseeHome®
|
Functional change over time with NT-501
|
Macular telangiectasia
|
Clinical
|
Notal Vision OCT Analyzer (NOA)
|
Automated detection of lesion activity with proprietary algorithm
|
Retinal diseases with fluid accumulation
|
Registration
|
Home-based Optical Coherence Tomography (OCT)
|
Home-based OCT testing in patients with retinal vascular diseases
|
Retinal diseases with fluid accumulation
|
Clinical
|
candidate
FORESEEHOME®
OVERVIEW
|
Demonstrate functional benefit in patients with good VA following ERM treatment |
DISEASE STATE
|
Epiretinal membrane |
STAGE OF DEVELOPMENT
|
Clinical |
FORESEEHOME®
OVERVIEW
|
Functional change over time with NT-501 |
DISEASE STATE
|
Macular telangiectasia |
STAGE OF DEVELOPMENT
|
Clinical |
NOTAL VISION OCT
ANALYZER (NOA)
OVERVIEW
|
Automated detection of lesion activity with proprietary algorithm |
DISEASE STATE
|
Retinal diseases with fluid accumulation |
STAGE OF DEVELOPMENT
|
Registration |
HOME-BASED
OPTICAL COHERENCE
TOMOGRAPHY (OCT)
OVERVIEW
|
Home-based OCT testing in patients with retinal vascular diseases |
DISEASE STATE
|
Retinal diseases with fluid accumulation |
STAGE OF DEVELOPMENT
|
Clinical |